GL1X · GenesisL1 explorer

UniProt P20536

Uracil-DNA glycosylase (P20536)

Uracil-DNA glycosylase (UniProt P20536): 14 experimental structures on GenesisL1, 1 ligand bound, 2 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P20536
Protein
Uracil-DNA glycosylase
Experimental structures
14
Predicted models
0
Ligands
1
Pockets
2 · 1 record with a druggable one

Structures

14 records of P20536 in the MolNFT archive: 14 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
4OD8Crystal structure of the vaccinia virus DNA polymerase holoenzyme subunit D4 in complex with the…x-ray diffractionB, A——
4OD8Crystal structure of the vaccinia virus DNA polymerase holoenzyme subunit D4 in complex with the…x-ray diffractionB, A——
4ODACrystal structure of the vaccinia virus DNA polymerase holoenzyme subunit D4 in complex with the…x-ray diffractionB, A——
4ODACrystal structure of the vaccinia virus DNA polymerase holoenzyme subunit D4 in complex with the…x-ray diffractionB, A——
4YGMVaccinia virus his-D4/A20(1-50) in complex with uracilx-ray diffractionB, A——
4YGMVaccinia virus his-D4/A20(1-50) in complex with uracilx-ray diffractionB, A——
4YIGvaccinia virus D4/A20(1-50) in complex with dsDNA containing an abasic site and free uracylx-ray diffractionA, E, I——
4YIGVaccinia virus D4/A20(1-50) in complex with dsdna containing an abasic site and free uracylx-ray diffractionA, E, I——
5JKRvaccinia virus D4/A20(1-50)w43a mutantx-ray diffractionB, ASO4—
5JKRVaccinia virus D4/A20(1-50)W43A mutantx-ray diffractionB, A——
5JKSvaccinia virus D4 R167A mutant /A20(1-50)x-ray diffractionB, ASO4—
5JKSVaccinia virus D4 R167A mutant /A20(1-50)x-ray diffractionB, A——
5JKTVaccinia virus D4 P173G mutant /A20(1-50)x-ray diffractionB, A——
8Q3RCryo-EM structure of the DNA polymerase holoenzyme E9-A20-D4 of vaccinia viruselectron microscopyD—2 (best 0.64)

Ligands

  • SO4 · Sulfate ion · in 2 records

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.